Summit Place Financial Advisors LLC Grows Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Summit Place Financial Advisors LLC raised its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 2.5% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 35,053 shares of the company’s stock after purchasing an additional 867 shares during the quarter. GE HealthCare Technologies comprises about 1.6% of Summit Place Financial Advisors LLC’s investment portfolio, making the stock its 29th biggest holding. Summit Place Financial Advisors LLC’s holdings in GE HealthCare Technologies were worth $2,740,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also added to or reduced their stakes in the company. Chapman Investment Management LLC boosted its holdings in shares of GE HealthCare Technologies by 0.4% in the 4th quarter. Chapman Investment Management LLC now owns 83,071 shares of the company’s stock worth $6,494,000 after purchasing an additional 292 shares during the period. Bank of Jackson Hole Trust purchased a new position in shares of GE HealthCare Technologies in the 4th quarter worth approximately $32,000. Braun Stacey Associates Inc. boosted its holdings in shares of GE HealthCare Technologies by 0.4% in the 4th quarter. Braun Stacey Associates Inc. now owns 221,509 shares of the company’s stock worth $17,318,000 after purchasing an additional 900 shares during the period. Atria Wealth Solutions Inc. boosted its holdings in GE HealthCare Technologies by 40.8% during the 4th quarter. Atria Wealth Solutions Inc. now owns 32,583 shares of the company’s stock valued at $2,547,000 after acquiring an additional 9,444 shares during the period. Finally, D.A. Davidson & CO. boosted its holdings in GE HealthCare Technologies by 89.7% during the 4th quarter. D.A. Davidson & CO. now owns 8,959 shares of the company’s stock valued at $700,000 after acquiring an additional 4,237 shares during the period. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Up 0.5 %

GE HealthCare Technologies stock opened at $92.67 on Wednesday. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. The business’s 50-day simple moving average is $84.45 and its two-hundred day simple moving average is $85.67. The company has a market cap of $42.38 billion, a PE ratio of 21.40, a PEG ratio of 3.05 and a beta of 1.15. GE HealthCare Technologies Inc. has a fifty-two week low of $74.51 and a fifty-two week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The business had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. Equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.66 EPS for the current year.

GE HealthCare Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th were given a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.15%. The ex-dividend date was Tuesday, January 14th. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s dividend payout ratio is currently 3.23%.

Analysts Set New Price Targets

GEHC has been the subject of a number of recent analyst reports. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their price objective for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. Citigroup boosted their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, February 13th. Finally, Wells Fargo & Company boosted their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a report on Friday, February 14th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $97.67.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.